Oramed Pharmaceuticals Inc (ORMP)
2.320
+0.02
(+0.87%)
USD |
NASDAQ |
May 23, 16:00
2.320
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Cash from Investing (Quarterly): 30.00M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 30.00M |
| December 31, 2023 | 30.00M |
| September 30, 2023 | -75.12M |
| June 30, 2023 | -14.71M |
| March 31, 2023 | -13.20M |
| December 31, 2022 | 11.26M |
| September 30, 2022 | 1.229M |
| June 30, 2022 | 10.36M |
| March 31, 2022 | 7.359M |
| November 30, 2021 | -99.05M |
| August 31, 2021 | -29.05M |
| May 31, 2021 | 7.394M |
| February 28, 2021 | -3.31M |
| November 30, 2020 | 1.199M |
| August 31, 2020 | 10.96M |
| May 31, 2020 | -13.24M |
| February 29, 2020 | 4.075M |
| November 30, 2019 | 2.825M |
| August 31, 2019 | 2.637M |
| May 31, 2019 | 4.177M |
| February 28, 2019 | 1.45M |
| November 30, 2018 | 2.995M |
| August 31, 2018 | -10.55M |
| May 31, 2018 | 3.90M |
| February 28, 2018 | 4.795M |
| Date | Value |
|---|---|
| November 30, 2017 | -5.146M |
| August 31, 2017 | 3.014M |
| May 31, 2017 | 2.637M |
| February 28, 2017 | 2.087M |
| November 30, 2016 | -3.436M |
| August 31, 2016 | -6.31M |
| May 31, 2016 | 2.242M |
| February 29, 2016 | -12.76M |
| November 30, 2015 | 0.818M |
| August 31, 2015 | -4.485M |
| May 31, 2015 | 3.65M |
| February 28, 2015 | -3.953M |
| November 30, 2014 | 1.476M |
| August 31, 2014 | 0.091M |
| May 31, 2014 | 0.115M |
| February 28, 2014 | -13.13M |
| November 30, 2013 | -0.162M |
| August 31, 2013 | -2.925M |
| May 31, 2013 | 0.1062M |
| February 28, 2013 | -2.204M |
| November 30, 2012 | 0.4542M |
| August 31, 2012 | 0.0232M |
| May 31, 2012 | 0.3402M |
| February 29, 2012 | 0.9566M |
| November 30, 2011 | 0.4489M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-99.05M
Minimum
Nov 2021
30.00M
Maximum
Mar 2024
-6.210M
Average
2.731M
Median
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | -14.04M |
| Cassava Sciences Inc | 0.00 |
| Vertex Pharmaceuticals Inc | -2.136B |
| Cormedix Inc | 8.945M |
| Oragenics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.476M |
| Cash from Financing (Quarterly) | -19.00M |
| Free Cash Flow | -6.279M |
| Free Cash Flow Per Share (Quarterly) | -0.0356 |
| Free Cash Flow Yield | -6.61% |